Nicole Beydon

Nicole Beydon

Auto-generated profile, based on publicly available information

Nicole Beydon

Sorbonne Université, APHP, Hôpital Armand Trousseau, Unité Fonctionnelle d'Explorations Fonctionnelles Respiratoire et Somnologie Paris Île‐de‐France France

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 February 2023 in European Respiratory Journal
Verified
Journal Article
Closed access
PDF file
NBNicole Beydon
Nicole Beydon
PKPanayiotis Kouis
Panayiotis Kouis
JMJune K. Marthin
June K. Marthin
PLPhilipp Latzin
Philipp Latzin
MCMurielle Colas
Murielle Colas
JLJane S Lucas
Jane S Lucas
Nasal nitric oxide (nNO) is extremely low in most people with primary ciliary dyskinesia (PCD) and its measurement is an important contributor to making the diagnosis. Existing guidelines and technical standards focus on nNO measurements in older, cooperative children using chemiluminescence analysers. However, measurements of nNO in pre-school-age children (age 2–5 years) may facilitate early diagnosis and electrochemical rather than chemiluminescence analysers are widely used. Pre-schoolers often need different methods to be employed when measuring nNO. Hence, a European Respiratory Society Task Force has developed this technical standard as the first step towards standardising sampling, analysis and reporting of nNO measured as part of the diagnostic testing for PCD in all age groups, including pre-school-age children. Furthermore, we considered both chemiluminescence and electrochemical analysers that are in use worldwide. There was a paucity of quality evidence for electrochemical analysers and sampling methods used in young children, and the Task Force proposes future research priorities to allow updates of this technical standard.

2 March 2015 in Pediatric Pulmonology
Verified
Journal Article
Closed access
PDF file
NBNicole Beydon
Nicole Beydon
ACArnaud Chambellan
Arnaud Chambellan
CACorinne Alberti
Corinne Alberti
JBJacques de Blic
Jacques de Blic
ACAnnick Clément
Annick Clément
MBMuriel Le Bourgeois
Muriel Le Bourgeois

18 November 2021 in ERJ Open Research
Verified
Journal Article
Open access
PDF file
AMAisling McGowan
Aisling McGowan
PLPierantonio Laveneziana
Pierantonio Laveneziana
SBSam BAYAT
Sam BAYAT
NBNicole Beydon
Nicole Beydon
PBPiotr W Boros
Piotr W Boros
FJFrans De Jongh
Frans De Jongh
Coronavirus disease 2019 (COVID-19) has negatively affected the delivery of respiratory diagnostic services across the world due to the potential risk of disease transmission during lung function testing. Community prevalence, reoccurrence of COVID-19 surges and the emergence of different variants of SARS-CoV-2 have impeded attempts to restore services. Finding consensus on how to deliver safe lung function services for both patients attending and for staff performing the tests are of paramount importance.This international statement presents the consensus opinion of 23 experts in the field of lung function and respiratory physiology balanced with evidence from the reviewed literature. It describes a robust roadmap for restoration and continuity of lung function testing services during the COVID-19 pandemic and beyond.Important strategies presented in this consensus statement relate to the patient journey when attending for lung function tests. We discuss appointment preparation, operational and environmental issues, testing room requirements including mitigation strategies for transmission risk, requirement for improved ventilation, maintaining physical distance and use of personal protection equipment. We also provide consensus opinion on precautions relating to specific tests, filters, management of special patient groups and alternative options to testing in hospitals.The pandemic has highlighted how vulnerable lung function services are and forces us to re-think how long-term mitigation strategies can protect our services during this and any possible future pandemic. This statement aspires to address the safety concerns that exist and provide strategies to make lung function tests and the testing environment safer when tests are required.

26 April 2014 in Sleep and Breathing
Verified
Journal Article
Closed access
PDF file
JPJade Pautrat
Jade Pautrat
SKSonia Khirani
Sonia Khirani
MBMichèle Boulé
Michèle Boulé
ARAdriana Ramirez
Adriana Ramirez
NBNicole Beydon
Nicole Beydon
BFBrigitte Fauroux
Brigitte Fauroux

30 January 2013 in Pediatric Radiology
Verified
Journal Article
Closed access
PDF file
NBNicole Beydon
Nicole Beydon
MLMichèle Larroquet
Michèle Larroquet
ACAurore Coulomb
Aurore Coulomb
JJJean-Marie Jouannic
Jean-Marie Jouannic
HPHubert Ducou le Pointe
Hubert Ducou le Pointe
CGCatherine Garel
Catherine Garel

25 April 2011 in Respirology
Verified
Journal Article
Closed access
PDF file
BMBruno Mahut
Bruno Mahut
CPClaudine Peiffer
Claudine Peiffer
PBPlamen Bokov
Plamen Bokov
CDChristophe Delclaux
Christophe Delclaux
NBNicole Beydon
Nicole Beydon